Everyone knows someone with cancer, so this question may be confusing, but: Does anyone have cancer anymore?
What I mean is: At first, there was cancer. Now, there is chronic myeloid leukemia and acute lymphocytic leukemia; primary colorectal lymphomas and gastrointestinal stromal tumors; and six subgroups of triple-negative breast cancer. We’ve outgrown the blanket term “cancer,” and it’s making a positive difference in how we treat and overcome disease.
In this piece, I’ll discuss breast cancer’s move from location-specific to genetic aberration categorization and treatment. With this in mind, I will reflect on the implications of using broad descriptors for disease, how technology can redefine disease and how we can transfer learnings from breast cancer to other diseases.
Read on to learn how Pepper is changing drug discovery.
Source: Forbes // See original post here.